References
- BeckersHJSchoutenJSWebersCARole of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertensionClin Ophthalmol2009359359919898664
- ManniGDenisPChewPThe safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertensionJ Glaucoma20091829330019365194
- KabackMScoperSVArzenoGIntraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%Ophthalmology20081151728173418538406
- SilverLHOcular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: Results from two multicenter comfort studies. Brinzolamide Comfort Study GroupSurv Ophthalmol200044Suppl 2S141S14510665516
- TsaiJCMcClureCARamosSECompliance barriers in glaucoma: A systematic classificationJ Glaucoma20031239339814520147
- KassMAGordonMMorleyREJrMeltzerDWGoldbergJJCompliance with topical timolol treatmentAm J Ophthalmol19971031881933812621
- SilverLHBrinzolamide Primary Therapy Study Group. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertensionAm J Ophthalmol19981264004089744373
- MichaudJEFrirenBthe International Brinzolamide Adjunctive Study GroupComparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertensionAm J Ophthalmol200113223524311476685
- DayDGSharpeEDAtkinsonMJThe clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patientsEye20062058359015933751
- StewartWCDayDGStewartJAShort-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjectsEye20041890591015002017
- MundorfTKRauchmanSHWilliamsRDNotivolRBrinzolamide/Timolol Preference Study GroupA patient preference comparison of Azarga (brinzolamide/timolol fixed combination) vs Cosopt (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertensionClin Ophthalmol2008262362819668763
- JampelHDSchwartzGFRobinALPatient preferences for eye drop characteristics: A willingness-to-pay analysisArch Ophthalmol200312154054612695251
- VoldSDEvansRMStewartRHWaltersTMallickSA one-week comfort study of BID-dosed brinzolamide 1%/timolol 0.5% ophthalmic suspension fixed combination compared to BID-dosed dorzolamide 2%/timolol 0.5% ophthalmic solution in patients with open-angle glaucoma or ocular hypertensionJ Ocul Pharmacol Ther20082460160519049301
- StrahlmanETippingRVogelRInternational Dorzolamide Study GroupA double masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxololArch Ophthalmol1995113100910167639651